XML 43 R31.htm IDEA: XBRL DOCUMENT v3.20.1
Stock Options and Awards (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 28, 2020
Mar. 30, 2019
Dec. 28, 2019
Minimum [Member]      
Stock Options [Abstract]      
Percentage of fair market value of stock on grant date for exercise price 100.00%    
Stock Options [Member]      
Number of Units, Stock Appreciation Rights (SARs) [Roll Forward]      
Outstanding at beginning of period (in shares) 25,000 25,000 25,000
Issued (in shares) 0 0 0
Forfeited (in shares) 0   0
Outstanding at end of period (in shares) 25,000   25,000
Weighted - Average Exercise Price, Stock Appreciation Rights (SARs) [Abstract]      
Outstanding at beginning of period (in dollars per share) $ 0 $ 0 $ 0
Issued (in dollars per share) 0   0
Forfeited (in dollars per share) 0   0
Outstanding at end of period (in dollars per share) 0   $ 0
SARs Grants Outstanding and Exercisable [Abstract]      
Maximum Range of Exercise Prices (in dollars per share) $ 0    
Outstanding (in shares) 25,000    
Weighted- Average Remaining Contractual Life 2 years    
Weighted- Average Exercise Price (in dollars per share) $ 0    
Exercisable (in shares) 0    
Exercisable, Weighted- Average Remaining Contractual life 0 years    
Exercisable, Weighted- Average Exercise Price (in dollars per share) $ 0    
Stock Appreciation Rights (SARs) [Member]      
Stock Options [Abstract]      
Stock-based compensation expense $ 110,000 $ 80,000  
Number of Units, Stock Appreciation Rights (SARs) [Roll Forward]      
Outstanding at beginning of period (in shares) 276,000 189,167 189,167
Issued (in shares) 0   96,000
Exercised (in shares) 0   (1,667)
Forfeited (in shares) (6,999)   (7,500)
Outstanding at end of period (in shares) 269,001   276,000
Weighted - Average Exercise Price, Stock Appreciation Rights (SARs) [Abstract]      
Outstanding at beginning of period (in dollars per share) $ 22.30 $ 21.46 $ 21.46
Issued (in dollars per share) 0   23.65
Exercised (in dollars per share) 0   19.10
Forfeited (in dollars per share) 19.10   21.20
Outstanding at end of period (in dollars per share) 22.39   $ 22.30
SARs Grants Outstanding and Exercisable [Abstract]      
Minimum Range of Exercise Prices (in dollars per share) 19.10    
Maximum Range of Exercise Prices (in dollars per share) $ 26.30    
Outstanding (in shares) 269,001    
Weighted- Average Remaining Contractual Life 3 years    
Weighted- Average Exercise Price (in dollars per share) $ 22.39    
Exercisable (in shares) 50,001    
Exercisable, Weighted- Average Remaining Contractual life 2 years    
Exercisable, Weighted- Average Exercise Price (in dollars per share) $ 19.10    
Restricted Stock [Member]      
Number of Units, Stock Appreciation Rights (SARs) [Roll Forward]      
Issued (in shares) 0 0  
Stock Options and SARs [Member]      
Stock Options [Abstract]      
Issued (in shares) 0 36,000  
SARs Grants Outstanding and Exercisable [Abstract]      
Outstanding options, intrinsic value $ 561,000    
2010 Plan [Member]      
Stock Options [Abstract]      
Expected term   3 years 6 months  
Volatility deviation   28.88%  
Risk free rate   2.48%  
Shares available for future grant (in shares) 0